Ongoing and Published work
The European Network for Sinonasal Cancer Research (EUSICA) - A pan-European initiative targeting a group of orphan tumours
https://pubmed.ncbi.nlm.nih.gov/38447380/
EUSICA/COST IMMUNO-model workshop fostering collaboration to advance sinonasal cancer research: A meeting report
https://pubmed.ncbi.nlm.nih.gov/37573683/
Sinonasal Cancer: Improving Classification, Stratification and Therapeutic Options
https://pubmed.ncbi.nlm.nih.gov/36980561/
DNA methylation-based classification of sinonasal tumors
https://pubmed.ncbi.nlm.nih.gov/36443295/
Molecular Basis and Rationale for the Use of Targeted Agents and Immunotherapy in Sinonasal Cancers
https://pubmed.ncbi.nlm.nih.gov/36431263/
Somatostatin receptor 2 expression in nasopharyngeal cancer is induced by Epstein Barr virus infection: impact on prognosis, imaging and therapy
https://pubmed.ncbi.nlm.nih.gov/33402692/
Clinical Outcomes, Kadish-INSICA Staging and Therapeutic Targeting of SSTR2 in Olfactory Neuroblastoma
https://pubmed.ncbi.nlm.nih.gov/34980502/
International Multicenter Study of Clinical Outcomes of Sinonasal Melanoma Shows Survival Benefit for Patients Treated with Immune Checkpoint Inhibitors and Potential Improvements to the Current TNM Staging System
PubMed coming soon
Precision medicine in rare tumors and the need for multicenter trials and international collaboratives: Sinonasal cancer as paradigm
https://pubmed.ncbi.nlm.nih.gov/32340860/
Coordinator
Matt Lechner, MD PhD (m.lechner@ucl.ac.uk)